The global Mefloquine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Mefloquine, a 4-quinolinemethanol compound, is an important antimalarial drug. It inhibits the growth of Plasmodium by disrupting mitochondrial function and DNA replication. With broad antimalarial activity against various Plasmodium species, including P. falciparum and P. vivax, it is well-absorbed orally, has a long half-life, and offers enduring efficacy. For prevention, weekly dosing suffices, while treatment requires only a short course. Widely used in malaria-endemic areas, it is especially valuable for chloroquine-resistant Plasmodium infections. It can also be combined with other antimalarials to enhance efficacy and delay resistance. However, mefloquine use is restricted due to potential severe neurological side effects like dizziness, insomnia, and anxiety, and rare but serious reactions such as psychiatric changes or arrhythmias. Risk-benefit evaluation and strict adherence to medical advice are essential for safe use.

Market Development Opportunities & Main Driving Factors

Mefloquine market growth is driven by malaria prevalence and rising drug resistance. In malaria-endemic regions like Africa and Southeast Asia, increasing chloroquine resistance boosts mefloquine demand as an alternative. Climate change and population movements are expanding malarias reach, further driving mefloquine need. Its preventive advantages make it a top choice for travelers and military personnel heading to high-risk malaria areas. Recent studies suggest mefloquines potential for greater role in combination therapies, creating new market opportunities. Also, public health policies in many countries support mefloquine use to combat malaria.

Market Challenges, Risks, & Restraints

Yet, the mefloquine market faces challenges. Its side effects, particularly severe neurological and psychiatric reactions, have led to stringent usage restrictions by many drug regulators, limiting demand. Also, it competes with multiple antimalarials like artemisinin-based combinations, each with their efficacy and safety advantages. Mefloquine must enhance cost-effectiveness and market recognition. Its complex production process, requiring advanced technology and equipment, raises costs and market entry barriers. Finally, growing Plasmodium resistance to mefloquine threatens its long-term competitiveness.

Downstream Demand Trends

For downstream demand, malaria treatment and prevention are the main mefloquine application fields. In treatment, rising Plasmodium resistance to traditional drugs keeps mefloquine relevant as a second-line therapy, especially in high-burden African and Southeast Asian regions. In prevention, rising international travel and business activities increase the number of people visiting malaria-endemic areas, providing steady growth for mefloquines preventive use. In the military sector, it remains crucial for protecting troops in high-risk areas. However, awareness of its side effects may reduce its preventive market share, confining its future use to tolerant specific groups. New antimalarials and vaccines could also squeeze its market share, but mefloquine will retain irreplaceability in certain regions and groups.

Infinity Market Research newest research report, the Mefloquine Industry Forecast looks at past sales and reviews total world Mefloquine sales in 2024, providing a comprehensive analysis by region and market sector of projected Mefloquine sales for 2025 through 2031. With Mefloquine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mefloquine industry.

This Insight Report provides a comprehensive analysis of the global Mefloquine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mefloquine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Mefloquine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mefloquine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mefloquine.

This report presents a comprehensive overview, market shares, and growth opportunities of Mefloquine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Purity 98%
    Purity 99%
    Others

Segmentation by Application:

    Chemical Industry
    Pharmaceutical Industry

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Toronto Research Chemicals
    Alfa Chemistry
    Waterstone Technology
    2A PharmaChem
    3B Scientific
    Chembest Research Laboratories
    Ningbo Taikang Chemical
    Hangzhou J&H Chemical
    Advanced Technology & Industrial
    GlaxoSmithKline
    Bayer
    Novartis
    Pfizer
    Hoffmann-La Roche
    Cipla
    Mylan
    Ipca Laboratories

Key Questions Addressed in this Report

What is the 10-year outlook for the global Mefloquine market?
What factors are driving Mefloquine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mefloquine market opportunities vary by end market size?
How does Mefloquine break out by Type, by Application?